| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Metabolic Syndrome |
0 |
1 |
| Fatty Liver |
0 |
0.58 |
| Liver Disease |
0 |
0.58 |
| Aminotransferase |
0 |
0.54 |
| Liver |
0 |
0.53 |
| Cardiovascular Risk Management |
0 |
0.46 |
| Heart |
0 |
0.41 |
| Liver Biopsy |
0 |
0.38 |
| Blood |
0 |
0.24 |
| Endocrinology |
0 |
0.24 |
| Lung |
0 |
0.24 |
| Nutrition |
0 |
0.24 |
| Oregon |
0 |
0.24 |
| Obesity |
0 |
0.22 |
| Cardiovascular disease |
0 |
0.12 |
| Metabolism |
0 |
0.12 |
| Preventive Screening |
0 |
0.12 |
| Biopsy |
0 |
0.06 |
| Body Mass Index |
0 |
0.06 |
| Diet |
0 |
0.06 |
| Dyslipidemia |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Genetics |
0 |
0.06 |
| Insulin Resistance |
0 |
0.06 |
| Nonalcoholic Steatohepatitis |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Thrombosis |
0 |
0.06 |
| Weight Loss |
0 |
0.06 |
| Genomic Medicine |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Thromboembolism |
0 |
0.03 |
| Weight Management |
0 |
0.03 |